Skip to content

8-KAccepted Oct 19, 4:51 PM ET

Supernus Pharmaceuticals: will report Q3 2026 results Oct 29

SUPERNUS PHARMACEUTICALS, INC.

Accepted (ET)

4:51 PM

Oct 19, 2026

Filed

Oct 19, 2026

Documents

13

Size

165.0 KB

Summary

Supernus Pharmaceuticals: will report Q3 2026 results Oct 29

Updated

What happened On Oct 19, 2026, Supernus Pharmaceuticals, Inc. issued a press release announcing that it will report its business results for the 3rd quarter of 2026 after the market closes on Thursday, Oct 29, 2026. The company will host a conference call and webcast on Thursday, Oct 29, 2026 at 4:30 p.m. E.T. to discuss its 3rd quarter 2026 financial and business results.

Key details

  • Press release issued on Oct 19, 2026.
  • Company will report 3rd-quarter 2026 business results after the market closes on Thursday, Oct 29, 2026.
  • Conference call and webcast scheduled for Thursday, Oct 29, 2026 at 4:30 p.m. E.T.

Why it may matter This filing reports Item 2.02: results of operations and financial condition, which covers the timing and format for the company’s release of 3rd-quarter 2026 results and the accompanying call to discuss financial and business results. The filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing